Format

Send to

Choose Destination
Blood Cancer J. 2019 Aug 20;9(9):68. doi: 10.1038/s41408-019-0227-3.

Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy.

Author information

1
Department of Radiation Oncology, Cancer Biology Division, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
2
Department of Medicine, Division of Medical Oncology, Washington University in St. Louis School of Medicine, Saint Louis, MO, USA.
3
GlycoMimetics Inc., Rockville, MD, USA.
4
Department of Radiation Oncology, Cancer Biology Division, Washington University in St. Louis School of Medicine, St. Louis, MO, USA. kareem.azab@wustl.edu.

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center